healthprotocol.wiki

deangelo_2018_cohort_midostaurin-phase2-advanced-sm-10-yr-follow-up

3 findings

Protocol
medication-midostaurin-oral-twice-daily
Outcome
biomarker-hematology-bone-marrow-mast-cell-burden-reduction-greater-than-50-percent-rate
n
26
effect
65
attribution
55
Protocol
medication-midostaurin-oral-twice-daily
Outcome
biomarker-tryptase-serum-reduction-greater-than-50-percent-rate
n
26
effect
45
attribution
55
Protocol
medication-midostaurin-oral-twice-daily
Outcome
oncology-complete-remission-rate
n
26
effect
20
attribution
55